News

Setting the standard for siloxane measurement in biomethane testing

Setting the standard for siloxane measurement in biomethane testing

Imspex Diagnostics recently partnered with the National Physical Laboratory (NPL), @KTNUK and @InnovateUK in their Analysis for Innovators (A4i) programme to investigate the utility of our GC-IMS technology combination for detecting and quantifying siloxanes from biomethane. This is an important collaboration, both from environmental and analytical method development perspectives. NPL will now propose GC-IMS as […]

Part of the Cell and Gene Therapy Catapult PAT Consortium

Part of the Cell and Gene Therapy Catapult PAT Consortium

Imspex is delighted to be part of the ground-breaking process analytical technologies (PAT) consortium announced today by the Cell and Gene Therapy Catapult. The consortium of over 20 pharmaceutical companies, technology providers, therapy developers and charities is the largest in the cell and gene therapy space to date with a mission to co-create industry-specific solutions […]

FlavourSpec® feasibly detects hepatocellular carcinoma urinary biomarkers in clinical practice

FlavourSpec® feasibly detects hepatocellular carcinoma urinary biomarkers in clinical practice

The Imspex Group’s proprietary gas chromatography-ion mobility spectrometry (GC-IMS) technology was part of a ground-breaking cancer detection study that was recently carried out by a team of researchers from the University of Warwick, Coventry University and the University of Leicester. In this study, the FlavourSpec® headspace analysis device showed that volatile organic compounds (VOCs) in […]

Into the future with breath analysis

Into the future with breath analysis

Human breath contains up to a thousand volatile organic compounds that, when analysed,  can tell a story about a body’s state of health. These chemical compounds reflect the end processes of metabolic pathways. Patterns of compound peaks form ‘signatures’ when breath is analysed into its components and it is these signatures that allow for disease […]

Breath analysis for COVID-19 screening in Vancouver

A rapid and non-invasive test that can identify whether COVID-19 is present or not can make all the difference in giving people peace of mind to attend appointments for existing medical conditions or to get going again with business, education and sporting activities. This is one of the driving factors for the work of Dr […]

GC-IMS for medical and healthcare applications

GC-IMS for medical and healthcare applications

Imspex Diagnostics’ proprietary GC-IMS analytical technology platform has built a legacy of being a versatile, accurate and robust analytical research tool in situations where compound combinations are complex and/ or concentrations are low. Much of this legacy has centred around volatile compounds in industrial and more recently environmental and food production settings. The ultra-highly sensitive […]

Breath analysis to detect COVID-19

Efforts to develop a quick and non-invasive breath test for the presence of COVID-19 are underway in Vancouver, British Columbia. Imspex’s BreathSpec® is one of a battery of tests that are being used by Dr Renelle Myers and her Vancouver Coastal Health team in their work to develop a breath test that identifies the possible […]

What quality is your olive oil?

High quality virgin and extra virgin olive oils are pure and healthy natural products remarkable for their complex and rich flavour. The assurance of best quality is of utmost importance for every party of its supply chain. The Flavourspec can be used for profiling of flavours in olive oil through headspace analysis. To find out […]

Breath analysis using GC-IMS

Breath analysis using GC-IMS

Remote breath sampling: Proof-of-principle – Monoterpene washout Myrtol® is a herbal medicine, the predominant active ingredients 1,8cineole and d-limonene (both >25%) are resorbed in to the blood stream via the small intestine. These monoterpenes are exhaled in the breath via gas exchange (alveolae| breath) in the lungs. The resorption and washout of cineole and limonene […]

Imspex’s patent portfolio grows

Imspex’s patent portfolio grows

Imspex Diagnostics’ patent portfolio recently grew, with news that the European Patent Office has granted the patent “Method for measuring human exhaled air”. This is the platform that is used to screen for disease indications such as bacterial and viral respiratory tract infections, Group B Streptococcus infection, lung cancer and other chronic inflammatory respiratory conditions. […]